Skip to content
  • Live News
  • Topics
  • Headlines
MarketNewsData
Essential Market News. Zero Noise.
  • Live News
  • Topics
  • Headlines

Category: Live News

Goldman Sachs predicts slower growth for major equity indexes like the S&P 500 in 2025

From Barchart: 2024-11-19 01:51:10 Goldman Sachs predicts slower growth for major equity indexes like the S&P 500 in 2025 due

November 19, 2024

Super Micro Computer launches liquid-cooled systems optimized for Nvidia GPUs, driving efficient AI solutions.

From Financial Modeling Prep: 2024-11-19 01:50:39 Super Micro Computer introduces direct liquid-cooled systems optimized for Nvidia’s Blackwell GPUs, enhancing efficiency,

November 19, 2024

AMD Chief Accounting Officer resigns, prompting concern over financial leadership impact

From Barchart: 2024-11-19 01:48:58 AMD has announced the resignation of its Chief Accounting Officer, sparking interest in the potential impact

November 19, 2024

Donald Trump's Truth Social platform in talks to acquire Bakkt, expanding into fintech and cryptocurrency.

From Financial Modeling Prep: 2024-11-19 01:48:12 Donald Trump’s Truth Social platform is in talks to acquire Bakkt, a digital asset

November 19, 2024

Biogen downgraded to Hold due to limited growth potential, struggling new product launches.

From None: 2024-11-18 12:46:00 Needham analysts downgraded Biogen (NASDAQ:BIIB) from Buy to Hold due to limited upside potential. Slow growth

November 18, 2024

Bright Horizons upgraded to Outperform with $125 price target, shares rose over 3%.

From Barchart: 2024-11-18 12:39:00 Bright Horizons (NYSE:BFAM) shares rose over 3% today after BMO Capital upgraded the stock to Outperform

November 18, 2024

KeyBanc lowers Monolithic Power Systems' price target due to market share concerns

From Financial Modeling Prep: 2024-11-18 12:28:00 KeyBanc analysts lowered Monolithic Power Systems’ price target from $1,075 to $700, citing concerns

November 18, 2024

Piper Sandler lowers Moderna price target to $69, citing short-term challenges but long-term growth potential

From Financial Modeling Prep: 2024-11-18 12:21:00 Piper Sandler analysts lowered Moderna’s price target to $69 but maintained an Overweight rating,

November 18, 2024

Piper Sandler raises Robinhood price target to $36, reflecting optimism in growth potential.

From Financial Modeling Prep: 2024-11-18 12:16:00 Piper Sandler analysts raised Robinhood Markets’ price target from $30 to $36 with an

November 18, 2024

Analysts maintain neutral rating on Dick's Sporting Goods with confidence in meeting expectations

From Financial Modeling Prep: 2024-11-18 12:14:00 Baird analysts maintain Neutral rating and $235 price target on Dick’s Sporting Goods (NYSE:DKS).

November 18, 2024

Golar LNG Limited (NASDAQ:GLNG) is a strong player in LNG industry with positive financial outlook.

From Financial Modeling Prep: 2024-11-18 04:00:03 Golar LNG Limited (NASDAQ:GLNG) is a key player in the LNG industry, focusing on

November 18, 2024

Jacobs Solutions Inc. (NYSE:J) expected to report strong quarterly earnings, beating estimates.

From Financial Modeling Prep: 2024-11-18 02:00:03 Jacobs Solutions Inc. (NYSE:J) is set to report quarterly earnings on November 19, 2024,

November 18, 2024

Walmart's upcoming earnings report for Q3 2025 is expected to show growth and profitability.

From Financial Modeling Prep: 2024-11-18 00:00:03 Walmart (NYSE:WMT) will announce Q3 2025 earnings with an expected EPS of $0.53 and

November 18, 2024

Strong capital efficiency for John Marshall Bancorp and Esquire Financial Holdings, Inc., but FVCBankcorp lags behind.

From None.: 2024-11-17 16:00:06 In the financial sector, John Marshall Bancorp, Inc. (NASDAQ:JMSB) demonstrates strong capital efficiency with a ROIC

November 17, 2024

JPMorgan Chase has lower ROIC compared to peers, but still efficient

From Financial Modeling Prep: 2024-11-17 16:00:05 JPMorgan Chase & Co. has a ROIC of 7.84% and a WACC of 11.58%,

November 17, 2024

AECOM's consensus price target increases to $128, indicating growing analyst optimism.

From Financial Modeling Prep: 2024-11-17 16:00:01 The consensus price target for AECOM (NYSE: ACM) has increased to $128 from $123.5,

November 17, 2024

Westlake Corporation declares dividend of $0.525 per share for Q3 2024, showing financial stability

From Financial Modeling Prep: 2024-11-17 14:00:04 Westlake Corporation, a chemical company based in Houston, has declared a dividend of $0.525

November 17, 2024

Analysts raise price target to $85 for Trip.com Group Limited, suggesting positive outlook.

From Financial Modeling Prep: 2024-11-17 07:00:01 Analyst price target for NASDAQ:TCOM has increased from $69.49 a year ago to $85

November 17, 2024

Origin Materials, Inc. reported lower than expected Q3 earnings and revenue, highlighting upcoming commercial production.

From Financial Modeling Prep: 2024-11-16 21:00:03 In Q3 2024, Origin Materials, Inc. reported an EPS of -$0.26, missing the expected

November 16, 2024

Agenus Inc. shows exceptional capital efficiency compared to industry peers.

From Financial Modeling Prep: 2024-11-16 16:00:04 Agenus Inc. (NASDAQ:AGEN) excels in capital efficiency with a 302.53% ROIC and 80.76% WACC.

November 16, 2024

Applied Materials beats Q4 estimates with EPS of $2.32 and revenue of $7.05 billion

From Financial Modeling Prep: 2024-11-15 08:00:00 Applied Materials (NASDAQ:AMAT) exceeded expectations for Q4 with adjusted EPS of $2.32 and revenue

November 15, 2024

Globant's shares fell 3% despite meeting analyst expectations in Q3

From Financial Modeling Prep: 2024-11-15 07:56:00 Globant S.A. (NYSE:GLOB) shares dropped over 3% in pre-market despite meeting analyst expectations in

November 15, 2024

JPMorgan downgrades bluebird bio to Underweight after Q3 results, facing financial challenges

From None: 2024-11-15 07:53:00 JPMorgan analysts downgraded bluebird bio (NASDAQ:BLUE) to Underweight due to financial challenges and limited capital-raising options

November 15, 2024

Goldman Sachs initiates neutral coverage on Doximity with a price target of $58

From Barchart: 2024-11-15 07:47:00 Goldman Sachs analysts started coverage on Doximity (NYSE:DOCS) with a Neutral rating and a price target

November 15, 2024

Guggenheim reaffirms a Buy rating on Cabaletta Bio with positive third-quarter results

From Barchart: 2024-11-15 07:37:00 Guggenheim analysts reiterated a Buy rating and $23 price target for Cabaletta Bio (NASDAQ:CABA) after positive

November 15, 2024

Posts pagination

Previous 1 … 137 138 139 … 199 Next
All Right Reserved © MarketNewsData.com.
  • Live News
  • Topics
  • Headlines
  • Contact Us
  • About Us
  • CCPA
  • Terms of Use
  • Privacy Policy
  • DMCA